BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14584277)

  • 1. [Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
    Oeda M; Hirabayashi N; Takiyama W; Nagamine I; Ohara M; Oshita A; Satou Y; Saeki S; Kirihara Y; Mukaida H; Hisamatu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1453-8. PubMed ID: 14584277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
    Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1403-12. PubMed ID: 11681248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
    Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
    Inaba Y; Watabe S; Ohe S; Kamio Y; Koyama M; Hayashi K; Chiba M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):239-44. PubMed ID: 11865630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of distant metastasis from advanced gastric cancer treated with TS-1, which maintained NC (no change) for 9 months].
    Nakao K; Fujiwara Y; Koishi K; Nishizaki K; Nakagawa K; Ooiwa N; Yamamura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1505-9. PubMed ID: 14584286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
    Tasaka K; Okada Y; Tomofuji Y; Chinzei T
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1631-5. PubMed ID: 12355951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Yabusaki H; Nashimoto A; Tanaka O
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session].
    Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1403-9. PubMed ID: 12214468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
    Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
    Ogino H; Misawa T; Nasu T; Ihara Y; Kubo S; Sadamoto Y; Harada N; Nakamura K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):833-6. PubMed ID: 15984526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment of far advanced and recurrent stomach cancer with TS-1].
    Johira H; Yunoki S; Kawata N; Watanabe N; Hachisuka Y; Kimura M; Uomoto M; Hatano H; Sanada E; Watanabe R; Ohmori K; Miyata N
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):195-9. PubMed ID: 15751632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
    Omatsu T; Ichikawa H; Kawahito Y; Ashihara E; Yamamoto A; Kadoya M; Takegami T; Takanashi Y; Naito Y; Yoshida N; Sugino S; Yoshikawa T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):869-73. PubMed ID: 12852359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
    Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
    Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
    Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Ohashi M; Kanda T; Yajima K; Banba T; Tanabe T; Kosugi S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1640-2. PubMed ID: 16315894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
    Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.